Two-stage implantation of the skin- and bone-integrated pylon seeded with autologous fibroblasts induced into osteoblast differentiation for direct skeletal attachment of limb prostheses

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 9, 2014, Pages 3033-3048

  Shevtsov, Maxim A ^a,b   Galibin, Oleg V ^b   Yudintceva, Nataliya M ^a   Blinova, Miralda I ^a   Pinaev, George P ^a   Ivanova, Anna A ^c   Savchenko, Olga N ^c   Suslov, Dmitriy N ^b   Potokin, Igor L ^d   Pitkin, Emil ^e   Raykhtsaum, Grigory ^f   Pitkin, Mark R ^f,g  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^c Russian Center for Research in Radiological and Surgical Technologies   (Russian Federation)

^d Institute for Highly Pure Biopreparations   (Russian Federation)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f Poly Orth International   (United States)

^g TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

autologous fibroblasts; direct skeletal attachment; osseointegration; prosthetic rehabilitation; skin and bone integrated pylon

Indexed keywords

BIOCOMPATIBILITY; BONE; CELL CULTURE; FIBROBLASTS; NUCLEAR MEDICINE; PROSTHETICS; TITANIUM;

DIRECT SKELETAL ATTACHMENT; HISTOLOGICAL ANALYSIS; IMPLANT SURFACE; INFLAMMATORY RESPONSE; OSSEOINTEGRATION; OSTEOBLAST DIFFERENTIATION; POROUS TITANIUM; PROSTHETIC REHABILITATIONS;

NEURAL PROSTHESES;

TITANIUM;

ABOVE KNEE AMPUTATION; ADHESION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; BONE; BONE DEVELOPMENT; BONE IMPLANT; BONE INTEGRATED PYLON; BONE REGENERATION; BONE SCINTISCANNING; CELL DENSITY; CELL DIFFERENTIATION; CONTROLLED STUDY; DIFFERENTIATION; ENCAPSULATION; EXPERIMENTAL RABBIT; FIBROBLAST; FOLLOW UP; HISTOLOGY; IN VIVO STUDY; LIMB PROSTHESIS; MALE; NONHUMAN; OSTEOBLAST; OSTEOMYELITIS; POROSITY; SCANNING ELECTRON MICROSCOPY; SKIN INTEGRATED PYLON; SOFT TISSUE; TISSUE DIFFERENTIATION; TISSUE IMPLANT; TRABECULAR BONE; TWO STAGE IMPLANTATION; ANIMAL; CHEMISTRY; CYTOLOGY; PROSTHESIS; RABBIT; TISSUE SCAFFOLD; TRANSPLANTATION;

ANIMALS; ARTIFICIAL LIMBS; FIBROBLASTS; MALE; OSSEOINTEGRATION; OSTEOBLASTS; OSTEOGENESIS; PROSTHESIS DESIGN; RABBITS; TISSUE SCAFFOLDS; TITANIUM;

EID: 84904810304     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34969     Document Type: Article

References (57)

1. Mooney V, Predecki PK, Renning J, Gray J,. Skeletal extension of limb prosthetic attachment-Problems in tissue reaction. J Biomed Mater Res 1971; 5: 143-159.
2. Mooney V, Schwartz SA, Roth AM, Gorniowsky MJ,. Percutaneous implant devices. Ann Biomed Eng 1977; 5: 34-46.
3. Branemark R, Branemark PI, Rydevik B, Myers RR,. Osseointegration in skeletal reconstruction and rehabilitation: A review. J Rehabil Res Dev 2001; 38: 175-181.
4. Hagberg K, Brånemark R,. One hundred patients treated with osseointegrated transfemoral amputation prostheses-Rehabilitation perspective. J Rehabil Res Dev 2009; 46: 331.
5. van de Meent H, Frölke JP, Palm B,. Preliminary results of the first 24 patients in the Netherlands. In: 4th Int. Conf. Advances in Orthopaedic Osseointegration, UCSF, San Francisco, February 10-12; 2012. p 31.
6. Al Muderis M, Bosley B, Kumar A, Laux S,. Early results of the osseointegration group of Australia accelerated protocol. In: 4th Int. Conf. Advances in Orthopaedic Osseointegration, UCSF, San Francisco, February 10-12; 2012. p 32.
7. Aschoff HH, Juhnke DL,. Evaluation of 10 years experience with endo-exo femur prostheses-background, data and results. Z Orthop Unfall 2012; 150: 607-614.
8. Aschoff HH, Kennon RE, Keggi JM, Rubin LE,. Transcutaneous, distal femoral, intramedullary attachment for above-the-knee prostheses: An endo-exo device. J Bone Joint Surg 2010; 92: 180-186.
9. Pitkin M,. Design features of the implants for direct skeletal attachment of limb prostheses. J Biomed Mater Res Part A 2013;00A. DOI:10.1002/jbm.a. 34606. http://onlinelibrary.wiley.com/doi/10.1002/jbm.a.34606/ abstract;jsessionid=E7EADFC8D11AC1347A767A49A713C1A8.d03t03? deniedAccessCustomisedMessage=&userIsAuthenticated=false.
10. Pendegrass CJ, Goodship AE, Blunn GW,. Development of a soft tissue seal around bone-anchored transcutaneous amputation prostheses. Biomaterials 2006; 27: 4183-4191.
11. Chimutengwende-Gordon M, Pendegrass C, Blunn G,. Enhancing the soft tissue seal around intraosseous transcutaneous amputation prostheses using silanized fibronectin titanium alloy. Biomed Mater 2011; 6: 025008.
12. Kang NV, Pendegrass C, Marks L, Blunn G,. Osseocutaneous integration of an intraosseous transcutaneous amputation prosthesis implant used for reconstruction of a transhumeral amputee: Case report. J Hand Surg Am 2010; 35: 1130-1134.
13. Fitzpatrick N, Smith TJ, Pendegrass CJ, Yeadon R, Ring M, Goodship AE, Blunn GW,. Intraosseous transcutaneous amputation prosthesis (ITAP) for limb salvage in 4 dogs. Vet Surg 2011; 40: 909-925.
14. Shelton TJ, Peter Beck J, Bloebaum RD, Bachus KN,. Percutaneous osseointegrated prostheses for amputees: Limb compensation in a 12-month ovine model. J Biomech 2011; 44: 2601-2606.
15. Jeyapalina S, Beck JP, Bachus KN, Williams DL, Bloebaum RD,. Efficacy of a porous-structured titanium subdermal barrier for preventing infection in percutaneous osseointegrated prostheses. J Orthop Res 2012; 30: 1304-1311.
16. Pitkin M, Raykhtsaum G, Pilling J, Galibin O, Protasov M, Chihovskaya J, Belyaeva I, Blinova M, Yudintseva M, Potokin I, Pinaev G, Moxson V, Duz V. Porous composite prosthetic pylon for integration with skin and bone. J Rehabil Res Dev 2007; 44: 723-738.
17. Pitkin M, Raykhtsaum G, Pilling J, Shukeylo Y, Moxson V, Duz V, Lewandowski J, Connolly R, Kistenberg R, Dalton J, Prilutsky B, Jacobson S,. Mathematical modeling and mechanical and histopathological testing of porous prosthetic pylon for direct skeletal attachment. J Rehabil Res Dev 2009; 46: 315-330.
18. Pitkin M, Pilling J, Raykhtsaum G,. Mechanical properties of totally permeable titanium composite pylon for direct skeletal attachment. J Biomed Mater Res Part B: Appl Biomater 2012; 100B: 993-999.
19. Pitkin M, Raykhtsaum G,. Skin integrated device. US Patent # 8257435; 2012.
20. Farrell B, Prilutsky B, Ritter J, Popat K, Pitkin M,. Effects of pore size, implantation time and nano-surface properties on rat skin ingrowth into percutaneous porous titanium implants. J Biomed Mat Res Part A. Forthcoming.
21. Goransson A, Gretzer C, Johansson A, Sul YT, Wennerberg A,. Inflammatory response to a titanium surface with potential bioactive properties: An in vitro study. Clin Implant Dent Relat Res 2006; 8: 210-217.
22. Jimbo R, Ono D, Hirakawa Y, Odatsu T, Tanaka T, Sawase T,. Accelerated photo-induced hydrophilicity promotes osseointegration: An animal study. Clin Implant Dent Relat Res 2011; 13: 79-85.
23. Del Fabbro M,. Clinical and radiographic evaluation of Branemark implants with an anodized surface following seven-to-eight years of functional loading. Int J Dent 2013; 2013.
24. Bencharit S, Byrd WC, Altarawneh S, Hosseini B, Leong A, Reside G, Morelli T, Offenbacher S,. Development and applications of porous tantalum trabecular metal-enhanced titanium dental implants. Clin Implant Dent Relat Res 2013. DOI: 10.1111/cid.12059.
25. Pitkin M, Raykhtsaum G, Galibin O, Protasov M, Chihovskaya J, Belyaeva I,. Skin and bone integrated prosthetic pylon: A pilot animal study. J Rehabil Res Dev 2006; 43: 573-580.
26. Pitkin M, Raykhtsaum G, Pilling J, Galibin OV, Protasov MV, Chihovskaya JV, Belyaeva IG, Blinova MI, Yudintseva NM, Potokin IL, Pinaev GP, Moxson V, Duz V,. Porous composite prosthetic pylon for integration with skin and bone. J Rehabil Res Dev 2007; 44: 723-738.
27. Farrell B, Pitkin M, Popat K, Prilutsky B. Effect of pore size, implantation time and nano-surface properties on rat skin ingrowth into porous titanium. In: 4th Int. Conf. Advances in Orthopaedic Osseointegration, UCSF, San Francisco, February 10-12; 2012. p 13.
28. Blinova M, Yudintzeva N, Nikolaenko N, Potokin I, Raykhtsaum G, Pitkin M, Pinaev G,. Cell cultivation on porous titanium implants with various structures. Cell Tissue Biol 2010; 4: 572-579.
29. Eidt J, Kalapatapu V,. Lower extremity amputation: Techniques and results. In:, Cronenwett J, editor. Rutherford's Vascular Surgery, 7th ed, Vol. 2. Philadelphia, PA: Saunders; 2010.
30. Wheeless CR,. Wheeless' textbook of orthopaedics. DataTrace Internet Pub; 2011. http://www.wheelessonline.com/ortho/triphasic-bone-scan.
31. Nutton RW, Fitzgerald RH Jr, Kelly PJ,. Early dynamic bone-imaging as an indicator of osseous blood flow and factors affecting the uptake of 99mTc hydroxymethylene diphosphonate in healing bone. J Bone Joint Surg Am 1985; 67: 763-770.
32. Mackie TJ, McCartney JE, Cruickshank R,. Mackie & McCartney's Handbook of Bacteriology; a Guide to the Laboratory Diagnosis and Control Of infection, 10th ed. Edinburgh: E. & S. Livingstone; 1960.
33. Winn WC, Koneman EW,. Koneman's Color Atlas and Textbook of Diagnostic Microbiology. Philadelphia: Lippincott Williams & Wilkins; 2006.
34. Siegel S, Castellan NJ,. Nonparametric Statistics for the Behavioral Sciences, 2nd ed. New York: McGraw-Hill; 1988.
35. Aschoff HH, McGough RL,. The endo-exo femoral prosthesis: A new rehabilitation concept following above knee amputation. J Bone Joint Surg Br Vol 2012; 94: 77-77.
36. Pitkin M, Cassidy C, Muppavarapu R, Edell D. Recording of electric signal passing through a pylon in direct skeletal attachment of leg prostheses with neuromuscular control. IEEE Trans Biomed Eng 2012; 59: 1349-1353.
37. Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, Sakamoto T, Nagatsu M, Kurosawa H,. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005; 129: 1330-1338.
38. L'Heureux N, Dusserre N, Marini A, Garrido S, de la Fuente L, McAllister T,. Technology insight: The evolution of tissue-engineered vascular grafts - from research to clinical practice. Nat Clin Pract Cardiovasc Med 2007; 4: 389-395.
39. Pawlowski KJ, Rittgers SE, Schmidt SP, Bowlin GL. Endothelial cell seeding of polymeric vascular grafts. Front Biosci 2004; 9: 1412-1421.
40. Hashi CK, Zhu Y, Yang GY, Young WL, Hsiao BS, Wang K, Chu B, Li S,. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci USA 2007; 104: 11915-11920.
41. Cho S-W, Lim SH, Kim I-K, Hong YS, Kim S-S, Yoo KJ, Park H-Y, Jang Y, Chang BC, Choi CY,. Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg 2005; 241: 506.
42. Salacinski HJ, Tiwari A, Hamilton G, Seifalian AM. Cellular engineering of vascular bypass grafts: Role of chemical coatings for enhancing endothelial cell attachment. Med Biol Eng Comput 2001; 39: 609-618.
43. Blanpain C, Horsley V, Fuchs E,. Epithelial stem cells: Turning over new leaves. Cell 2007; 128: 445-458.
44. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA,. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121: 335-348.
45. Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, Brown PO,. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 2002; 99: 12877-12882.
46. McGettrick HM, Smith E, Filer A, Kissane S, Salmon M, Buckley CD, Rainger GE, Nash GB. Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells. Eur J Immunol 2009; 39: 113-125.
47. Haniffa MA, Wang XN, Holtick U, Rae M, Isaacs JD, Dickinson AM, Hilkens CM, Collin MP,. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol 2007; 179: 1595-1604.
48. Lysy PA, Smets F, Sibille C, Najimi M, Sokal EM,. Human skin fibroblasts: From mesodermal to hepatocyte-like differentiation. Hepatology 2007; 46: 1574-1585.
49. da Silva Meirelles L, Chagastelles PC, Nardi NB,. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119: 2204-2213.
50. Bieback K, Kluter H,. Mesenchymal stromal cells from umbilical cord blood. Curr Stem Cell Res Ther 2007; 2: 310-323.
51. Sagnella S, Anderson E, Sanabria N, Marchant RE, Kottke-Marchant K,. Human endothelial cell interaction with biomimetic surfactant polymers containing peptide ligands from the heparin binding domain of fibronectin. Tissue Eng 2005; 11: 226-236.
52. Sun T, Jackson S, Haycock JW, MacNeil S. Culture of skin cells in 3D rather than 2D improves their ability to survive exposure to cytotoxic agents. J Biotechnol 2006; 122: 372-381.
53. Cukierman E, Pankov R, Yamada KM,. Cell interactions with three-dimensional matrices. Curr Opin Cell Biol 2002; 14: 633-639.
54. Hakkinen KM, Harunaga JS, Doyle AD, Yamada KM. Direct comparisons of the morphology, migration, cell adhesions, and actin cytoskeleton of fibroblasts in four different three-dimensional extracellular matrices. Tissue Eng Part A 2011; 17: 713-724.
55. Kawano M, Taki J, Tsuchiya H, Tomita K, Tonami N,. Predicting the outcome of distraction osteogenesis by 3-phase bone scintigraphy. J Nucl Med 2003; 44: 369-374.
56. Rheinwald JG, Green H,. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature 1977; 265: 421-424.
57. Nebergall A, Bragdon C, Antonellis A, Körrholm J, Brånemark R, Malchau H,. Stable fixation of an osseointegated implant system for above-the-knee amputees. Acta Orthop 2012; 83: 121-128.